Search research articles
Contact Us
Filters
Showing results (71-80 of 139) with videos related to
Page
of 14
Sort By:
Scientific Reports
|
October 19, 2017
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease
Tobias Skillbäck, Niklas Mattsson, Karl Hansson, et al.
Molecular Neurodegeneration
|
February 22, 2017
Ex vivo <sup>18</sup>O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
Erik Portelius, Niklas Mattsson, Josef Pannee, et al.
Clinical Chemistry and Laboratory Medicine
|
January 29, 2023
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood
Ulf Andreasson, Johan Gobom, Vincent Delatour, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry
Josef Pannee, Johan Gobom, Leslie M Shaw, et al.
Translational Neurodegeneration
|
April 9, 2024
Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics
Daniela Moutinho, Vera M Mendes, Alessandro Caula, et al.
Molecular and Cellular Biology
|
July 4, 2012
Functional analysis of centrosomal kinase substrates in Drosophila melanogaster reveals a new function of the nuclear envelope component otefin in cell cycle progression
Karin Habermann, Ekaterina Mirgorodskaya, Johan Gobom, et al.
Brain : a Journal of Neurology
|
February 7, 2024
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
Johanna Nilsson, Alexa Pichet Binette, Sebastian Palmqvist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 12, 2022
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders
Johanna Nilsson, Julius Constantinescu, Bengt Nellgård, et al.
Parkinsonism & Related Disorders
|
August 17, 2023
α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders
Bárbara Fernandes Gomes, Carly M Farris, Yihua Ma, et al.
Alzheimer'S Research & Therapy
|
March 8, 2016
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
Mikko Hölttä, Robert A Dean, Eric Siemers, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 139) with videos related to
Sort By:
Page
of 14
Scientific Reports
|
October 19, 2017
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease
Tobias Skillbäck, Niklas Mattsson, Karl Hansson, et al.
Molecular Neurodegeneration
|
February 22, 2017
Ex vivo <sup>18</sup>O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
Erik Portelius, Niklas Mattsson, Josef Pannee, et al.
Clinical Chemistry and Laboratory Medicine
|
January 29, 2023
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood
Ulf Andreasson, Johan Gobom, Vincent Delatour, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry
Josef Pannee, Johan Gobom, Leslie M Shaw, et al.
Translational Neurodegeneration
|
April 9, 2024
Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics
Daniela Moutinho, Vera M Mendes, Alessandro Caula, et al.
Molecular and Cellular Biology
|
July 4, 2012
Functional analysis of centrosomal kinase substrates in Drosophila melanogaster reveals a new function of the nuclear envelope component otefin in cell cycle progression
Karin Habermann, Ekaterina Mirgorodskaya, Johan Gobom, et al.
Brain : a Journal of Neurology
|
February 7, 2024
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
Johanna Nilsson, Alexa Pichet Binette, Sebastian Palmqvist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 12, 2022
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders
Johanna Nilsson, Julius Constantinescu, Bengt Nellgård, et al.
Parkinsonism & Related Disorders
|
August 17, 2023
α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders
Bárbara Fernandes Gomes, Carly M Farris, Yihua Ma, et al.
Alzheimer'S Research & Therapy
|
March 8, 2016
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
Mikko Hölttä, Robert A Dean, Eric Siemers, et al.
Page
of 14